3D Global Biotech Inc. (TPEX:6808)
Taiwan
· Delayed Price · Currency is TWD 34.60
-1.30 (-3.62%)
Apr 29, 2026, 1:25 PM CST
3D Global Biotech Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Market Capitalization | 2,764 | 3,760 | 5,131 | 1,088 | 1,498 | 2,143 | Upgrade
|
| Market Cap Growth | -39.93% | -26.72% | 371.49% | -27.35% | -30.09% | -18.98% | Upgrade
|
| Enterprise Value | 2,335 | 3,076 | 4,797 | 915 | 1,295 | 1,901 | Upgrade
|
| Last Close Price | 35.90 | 48.30 | 66.14 | 19.00 | 26.32 | 38.77 | Upgrade
|
| PE Ratio | 42.74 | 56.51 | 55.95 | - | - | - | Upgrade
|
| PS Ratio | 13.37 | 18.19 | 19.31 | 52.74 | 109.79 | 193.46 | Upgrade
|
| PB Ratio | 2.81 | 3.82 | 5.67 | 3.71 | 4.40 | 5.50 | Upgrade
|
| P/TBV Ratio | 3.03 | 4.13 | 6.28 | 5.69 | 6.70 | 9.03 | Upgrade
|
| P/FCF Ratio | 26.39 | 35.90 | 344.12 | - | - | - | Upgrade
|
| P/OCF Ratio | 24.92 | 33.90 | 261.08 | - | - | - | Upgrade
|
| EV/Sales Ratio | 11.29 | 14.88 | 18.05 | 44.33 | 94.89 | 171.68 | Upgrade
|
| EV/EBITDA Ratio | 33.84 | 52.89 | 45.85 | - | - | - | Upgrade
|
| EV/EBIT Ratio | 56.33 | 74.20 | 54.20 | - | - | - | Upgrade
|
| EV/FCF Ratio | 22.29 | 29.37 | 321.70 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.05 | 0.05 | 0.09 | 0.04 | 0.05 | 0.06 | Upgrade
|
| Debt / EBITDA Ratio | 0.71 | 0.71 | 0.77 | - | - | - | Upgrade
|
| Debt / FCF Ratio | 0.47 | 0.47 | 5.69 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.43 | -0.43 | -0.68 | -0.53 | -0.56 | -0.54 | Upgrade
|
| Net Debt / EBITDA Ratio | -7.37 | -7.37 | -5.92 | 3.35 | 4.07 | 4.99 | Upgrade
|
| Net Debt / FCF Ratio | -4.09 | -4.09 | -41.52 | 4.81 | 5.43 | 5.45 | Upgrade
|
| Asset Turnover | 0.19 | 0.19 | 0.39 | 0.06 | 0.03 | 0.02 | Upgrade
|
| Inventory Turnover | 3.96 | 3.96 | 17.14 | 4.41 | 5.14 | 9.16 | Upgrade
|
| Quick Ratio | 13.49 | 13.49 | 15.75 | 6.34 | 10.41 | 15.71 | Upgrade
|
| Current Ratio | 14.08 | 14.08 | 15.93 | 6.63 | 10.71 | 16.04 | Upgrade
|
| Return on Equity (ROE) | 7.04% | 7.04% | 15.31% | -18.28% | -18.37% | -14.24% | Upgrade
|
| Return on Assets (ROA) | 2.44% | 2.44% | 8.12% | -11.30% | -10.41% | -8.57% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.46% | 9.85% | 39.90% | -43.84% | -40.57% | -33.56% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.90% | 3.90% | 9.00% | -21.10% | -18.90% | -15.20% | Upgrade
|
| Earnings Yield | 2.41% | 1.77% | 1.79% | -5.33% | -4.48% | -2.79% | Upgrade
|
| FCF Yield | 3.79% | 2.79% | 0.29% | -2.98% | -2.36% | -1.81% | Upgrade
|
| Dividend Yield | 0.28% | 0.21% | 0.80% | - | - | - | Upgrade
|
| Payout Ratio | 62.03% | 62.03% | - | - | - | - | Upgrade
|
| Buyback Yield / Dilution | -11.92% | -11.92% | -26.08% | -2.32% | -1.69% | -0.77% | Upgrade
|
| Total Shareholder Return | -11.63% | -11.71% | -25.27% | -2.32% | -1.69% | -0.77% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.